NASDAQ:IDXX

IDEXX Laboratories Earning Date

USA |NASDAQ |USD

IDXX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 2, 2021 Sep 2021 $1.91 $2.34 $1.69
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 2, 2021 Sep 2021 $798.16M $826.14M $721.79M

Idexx Laboratories's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 2021.

IDXX Earnings Date & History Chart

IDXX Earnings & Revenue Forecast

IDXX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 8 $1.80 $1.68 $2.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $8.38 $8.27 $8.76
Dec 2022 10 $9.38 $8.59 $9.97

IDXX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $1.81 $1.81 $1.86
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 2 / 0 $8.37 $8.37 $8.11
Dec 2022 1 / 0 $9.35 $9.35 $9.11

IDXX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 8 $793.18M $785.10M $806.80M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 9 $3.20B $3.18B $3.22B
Dec 2022 9 $3.55B $3.49B $3.60B

IDXX Earnings Date & Revenue History

IDXX Earnings History

|
Show More
Show More

IDXX Revenue History

|
Show More
Show More

Idexx Laboratories Next Earnings Date & Report

IDXX Next Earnings Date & Report Preview: Sep 2021 (FQ)

IDXX's next earnings date is Tuesday, Nov 2, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 8 analysts, the average EPS estimation for Idexx Laboratories's next quarterly earnings is $1.91, with a low EPS estimation of $1.66, and a high estimation of $2.07.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 0 downward. The EPS 1 month trend is $1.89, the last 2 month trend is $1.89, and the 3 month trend is $1.90.

Based on 9 analysts, the average revenue estimation is $798.16M, with a low revenue estimation of $785.50M, and a high estimation of $806.85M.

Idexx Laboratories Previous Earnings Dates & Reports

IDXX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Idexx Laboratories's previous earnings date was Jul 30, 2021 for its fiscal quarter ended Jun 30, 2021.

IDXX's earnings per share (EPS) was $2.34, beating the consensus analysts forecast of $2.04 by 14.63%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by -0.43%, and higher than the same period a year before (Jun 2020) by 36.05%.

Revenues were $826.14M, better than the forecast of $786.32M by 5.06%, up by 6.23% from the previous quarter , and up by 29.57% from the same period last year.

The company reported a net income of $202.58M, -0.82% lower than the previous quarter, and higher by 36.02% than the same period a year before.

Free cash flow for the quarter was $211.37M , compared to $104.26M last quarter and $183.59M a year before.

IDXX ended the quarter with $1.01B in total debt, an increase of 1.28% compared to the previous quarter, and a decrease of -0.84% compared to the same quarter a year before.

IDXX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Idexx Laboratories's previous annual earnings date was Feb 2, 2021 for its fiscal year ended Dec 31, 2020.

IDXX's earnings per share (EPS) was $6.46, beating the consensus analysts forecast of $6.08 by 6.25% , and higher than the previous year's EPS (Dec 2019) by 32.38%.

Revenues were $2.71B, better than the forecast of $2.67B by 1.43%, and up by 12.45% from previous year's revenue.

The company reported a net income of $581.78M, 36.02% higher than the previous year.

Idexx Laboratories reported a free cash flow of $540.19M for its fiscal year, compared to $303.93M a year ago.

The company ended the fiscal year with $926.21M in total debt, a decrease of -7.65% compared to the previous year.